HomePMCB • NASDAQ
add
Pharmacyte Biotech Inc
Previous close
$0.96
Day range
$0.94 - $0.97
Year range
$0.80 - $2.42
Market cap
6.51M USD
Avg Volume
94.16K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jul 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 848.30K | -33.15% |
Net income | -8.36M | -135.69% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jul 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 13.44M | -58.82% |
Total assets | 45.11M | -35.74% |
Total liabilities | 1.52M | -91.15% |
Total equity | 43.59M | — |
Shares outstanding | 6.80M | — |
Price to book | 0.15 | — |
Return on assets | -4.23% | — |
Return on capital | -4.44% | — |
Cash Flow
Net change in cash
| (USD) | Jul 2025info | Y/Y change |
|---|---|---|
Net income | -8.36M | -135.69% |
Cash from operations | -1.99M | -434.15% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -1.99M | 88.64% |
Free cash flow | -1.15M | -130.92% |
About
Founded
1996
Headquarters
Website
Employees
2
